Medicine & Health

Tristan J. McIntosh, an assistant professor of medicine at the School of Medicine, has received a $1.4 million grant from the National Institutes of Health (NIH) to study ethical collaborations between academia and industry in the development of brain technologies.

Meghan Campbell, an associate professor of neurology and of radiology at the School of Medicine, and Caterina Gratton, of Florida State University, have received a five-year $3 million award from the National Institutes of Health (NIH) to image functional brain networks in people with Parkinson’s disease.

A new study by Zachariah Reagh in Arts & Sciences offers fresh insights into how the brain goes to great lengths to process and remember everyday events.

New research from the School of Medicine’s Guoyan Zhao and colleagues provides guidance for future study to understand the role of glia in disease pathogenesis using mouse models. The work is published in Nature Aging.

Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at the School of Medicine, has been named a winner of the Rainwater Annual Prize for Outstanding Innovation in Neurodegenerative Disease Research.

In the seminar “Cognitive Illusions,” students in psychological and brain sciences examine the causes and consequences of errors in thinking.

Researchers at Washington University School of Medicine have discovered that the fluid around the brain flows to areas critical for normal brain development and function, suggesting that disruptions to its circulation may play an underrecognized role in neurodevelopmental disorders.

Research from the lab of Hong Chen, at the McKelvey School of Engineering and the School of Medicine, and collaborators found that using focused-ultrasound-mediated liquid biopsy in a mouse model released more tau proteins and another biomarker into the blood than without the intervention. This noninvasive method could facilitate diagnosis of neurodegenerative disorders.

Researchers at Washington University School of Medicine have discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.

Seniors Sam Norwitz and Ephraim Oyetunji, both majoring in neuroscience in Arts & Sciences, were finalists for the Rhodes Scholarship, one of the world’s most prestigious academic honors.